Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Primary CNS Lymphoma.

Grommes C, DeAngelis LM.

J Clin Oncol. 2017 Jul 20;35(21):2410-2418. doi: 10.1200/JCO.2017.72.7602. Epub 2017 Jun 22. Review.

2.

Treatment of primary central nervous system lymphoma.

Ekenel M, DeAngelis LM.

Curr Neurol Neurosci Rep. 2007 May;7(3):191-9. Review.

PMID:
17488584
3.

Diagnosis and management of primary central nervous system lymphoma.

Han CH, Batchelor TT.

Cancer. 2017 Nov 15;123(22):4314-4324. doi: 10.1002/cncr.30965. Epub 2017 Sep 26. Review.

PMID:
28950405
4.

Treatment of primary central nervous system lymphoma.

Ekenel M, Deangelis LM.

Curr Treat Options Neurol. 2007 Jul;9(4):271-82.

PMID:
17580007
5.

Primary central nervous system lymphoma.

Gerstner ER, Batchelor TT.

Arch Neurol. 2010 Mar;67(3):291-7. doi: 10.1001/archneurol.2010.3. Review.

PMID:
20212226
6.

Primary CNS lymphoma.

Batchelor T, Loeffler JS.

J Clin Oncol. 2006 Mar 10;24(8):1281-8. Review.

PMID:
16525183
7.

High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).

Schorb E, Finke J, Ferreri AJ, Ihorst G, Mikesch K, Kasenda B, Fritsch K, Fricker H, Burger E, Grishina O, Valk E, Zucca E, Illerhaus G.

BMC Cancer. 2016 Apr 21;16:282. doi: 10.1186/s12885-016-2311-4.

8.

Treatment of Primary Central Nervous System Lymphoma: From Chemotherapy to Small Molecules.

Mendez JS, Grommes C.

Am Soc Clin Oncol Educ Book. 2018 May 23;(38):604-615. doi: 10.1200/EDBK_200829.

9.

Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network.

Langner-Lemercier S, Houillier C, Soussain C, Ghesquières H, Chinot O, Taillandier L, Soubeyran P, Lamy T, Morschhauser F, Benouaich-Amiel A, Ahle G, Moles-Moreau MP, Moluçon-Chabrot C, Bourquard P, Damaj G, Jardin F, Larrieu D, Gyan E, Gressin R, Jaccard A, Choquet S, Brion A, Casasnovas O, Colin P, Reman O, Tempescul A, Marolleau JP, Fabbro M, Naudet F, Hoang-Xuan K, Houot R.

Neuro Oncol. 2016 Sep;18(9):1297-303. doi: 10.1093/neuonc/now033. Epub 2016 Mar 6.

10.

Atypical presentation of primary central nervous system non-Hodgkin lymphoma in immunocompetent young adults.

Cheatle JT, Aizenberg MR, Weinberg JS, Surdell DL.

World Neurosurg. 2013 Mar-Apr;79(3-4):593.e9-13. doi: 10.1016/j.wneu.2012.07.026. Epub 2012 Aug 7.

PMID:
22885166
11.

Primary CNS lymphoma in immunocompetent patients.

Sierra del Rio M, Rousseau A, Soussain C, Ricard D, Hoang-Xuan K.

Oncologist. 2009 May;14(5):526-39. doi: 10.1634/theoncologist.2008-0236. Epub 2009 May 11. Review.

12.

Primary central nervous system lymphoma: overview of current treatment strategies.

Brastianos PK, Batchelor TT.

Hematol Oncol Clin North Am. 2012 Aug;26(4):897-916. doi: 10.1016/j.hoc.2012.05.003. Review.

PMID:
22794289
13.

[Primary central nervous system lymphomas].

Hrudková M, Belada D, Smolej L, Zák P, Malý J.

Vnitr Lek. 2010 Aug;56(8):795-800. Review. Czech.

PMID:
20845611
14.

Primary central nervous system lymphoma.

Citterio G, Reni M, Gatta G, Ferreri AJM.

Crit Rev Oncol Hematol. 2017 May;113:97-110. doi: 10.1016/j.critrevonc.2017.03.019. Epub 2017 Mar 18. Review.

PMID:
28427529
15.

Primary central nervous system lymphoma: essential points in diagnosis and management.

Paydas S.

Med Oncol. 2017 Apr;34(4):61. doi: 10.1007/s12032-017-0920-7. Epub 2017 Mar 17. Review.

PMID:
28315229
16.

Challenges and opportunities in primary CNS lymphoma: A systematic review.

Kerbauy MN, Moraes FY, Lok BH, Ma J, Kerbauy LN, Spratt DE, Santos FP, Perini GF, Berlin A, Chung C, Hamerschlak N, Yahalom J.

Radiother Oncol. 2017 Mar;122(3):352-361. doi: 10.1016/j.radonc.2016.12.033. Epub 2017 Jan 16. Review.

PMID:
28104300
17.

Primary central nervous system lymphoma.

Batchelor TT.

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):379-385. Review.

PMID:
27913504
18.

Advances in Primary Central Nervous System Lymphoma.

Patrick LB, Mohile NA.

Curr Oncol Rep. 2015 Dec;17(12):60. doi: 10.1007/s11912-015-0483-8. Review.

PMID:
26475775
19.

Treatment options for central nervous system lymphomas in immunocompetent patients.

Jahnke K, Thiel E.

Expert Rev Neurother. 2009 Oct;9(10):1497-509. doi: 10.1586/ern.09.100.

PMID:
19831839
20.

Haematopoietic stem cell transplantation for treatment of primary CNS lymphoma: single-centre experience and literature review.

Bojic M, Berghoff AS, Troch M, Agis H, Sperr WR, Widhalm G, Wöhrer A, Kalhs P, Preusser M, Rabitsch W.

Eur J Haematol. 2015 Jul;95(1):75-82. doi: 10.1111/ejh.12482. Epub 2015 Mar 23. Review.

PMID:
25546348

Supplemental Content

Support Center